Abstract
At some time in their life, 15% of people with diabetes develop foot ulcers, which are highly susceptible to infection. Foot infection in diabetes may spread rapidly leading to overwhelming tissue destruction and amputation. Management of infection in diabetic foot needs a multidisciplinary approach and it is vital to achieve microbiological, wound, vascular, mechanical, and educational control. If infection is not controlled it can spread rapidly, causing extensive tissue necrosis and taking the foot into stage 5. At presentation, the organism responsible for infection cannot be predicted from clinical experience. However, antibiotic selection should be empirical and initially related to patient factors and the severity of the infection. In general, acute diabetic foot infections without prior antibiotic treatment are caused by aerobic Gram-positive organism and most commonly by Staphylococcus aureus (including methicillin-resistant strains). With time, the wound microbiologically becomes polymicrobial and includes anaerobes. For more severe infection, antibiotics with broad-spectrum coverage until culture results and clinical response is available should be prescribed. Coverage for methicillin-resistant organism (MRSA) should be considered based on local epidemiology and risk factors. The duration of treatment depends on the severity of infection, the involvement of bone and the patient’s response to treatment. Empirical antibiotic treatment, however, is not recommended for clinically uninfected wound.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Singh N, Armstrong DG, Lipsky BA (2005) Preventing foot ulcers in patients with diabetes. JAMA 293:217–228
National Diabetes Fact Sheet (2011) US Department of Health and Human Services. Atlanta, GA, Center for Disease Control and Prevention, p 2011
Prompers L, Huijberts M, Apelqvist J et al (2007) High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia 50:18–25
International Working Group on the Diabetic Foot (1999) International consensus on the diabetic foot. Amsterdam, pp 1–96
Pecoraro RE, Ahroni JH, Boyko EJ, Stencil VL (1991) Chronology and determinants of tissue repair in diabetic lower-extremity ulcers. Diabetes 40:1305–1313
Reiber GE, Pecoraro RE, Koepsell TD (1992) Risk factors for amputation in patients with diabetes mellitus: a case control study. Ann Intern Med 117:97–105
Peters EJ, Lipsky BA (2013) Diagnosis and management of infection in the diabetic foot. Med Clin North Am 97:911–946
Nather A, Bee CS, Huak CY, Chew JL, Lin CB, Neo S, Sim EY (2008) Epidemiology of diabetic foot problems and predictive factors for limb loss. J Diabetes Complications 22:77–82
Uckay I, Gariani K, Pataky Z, Lipsky BA (2014) Diabetic foot infections: state-of-the-art. Diabetes Obes Metab 16:305–316
Miyan Z, Fawwad A, Sabir R, Basit A (2017) Microbiological pattern of diabetic foot infections at a tertiary care center in a developing country. J Pak Med Assoc 67:665–669
Armstrong DG, Lavery LA (1998) Diabetic foot ulcers: prevention, diagnosis and classification. Am Fam Physician 57:1325–1332
Zubair M, Malik A, Ahmad J (2011) Clinico-microbial study and anti-microbial drug resistance profile of diabetic foot infections in North India. Foot 21:6–14
Zubair M, Malik A, Ahmad J (2012) Study of plasmid-mediated extended-spectrum b-lactamase-producing strains of enterobacteriaceae, isolated from diabetic foot infections in a North Indian tertiary-care hospital. Diabetes Technol Ther 14(4):315–324
Young MJ, Boulton AJ, Macleod AF et al (1993) A multicentric study of the prevalence of diabetic peripheral neuropathy in the United Kingdom Hospital clinic population. Diabete 36:150–154
Reiber GE, Vileikyte L, Boyko EJ, del Aguila M, Smith DG, Lavery LA et al (1999) Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care 22:157–162
Noor S, Zubair M, Ahmad J et al (2015) Diabetic foot ulcer—a review on pathophysiology, classification and microbial etiology. Diabetes Metab Syndr 9:192–199
Ahmad J (2016) The diabetic foot. Diabetes Metab Syndr 10:48–60
The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus. N Eng J Med 329(14):977–986
Marston WA, Davies SW, Armstrong B et al (2006) Natural history of limbs with arterial insufficiency and chronic ulceration treated with revascularization. J Vasc Surg 44:108–114
Bridges RM Jr, Deitch EA (1994) Diabetic foot infections. Path physiology and treatment. Surg Clin North Am 74:537–555
Hostetter MK (1990) Perspectives in diabetes. Handicaps to host defense. Effects of hyperglycemia on C3 and Candida albicans. Diabetes 39:271–275
Geerlings SE, Brouwer EC, Gaastra W, Verhoef J, Hoepelman AIM (1999) The effect of glucose and pH on uropathogenic and non-uropathogenic Escherichia coli: studies using urine from diabetics and non-diabetics. J Med Microbiol 48:535–539
Schram JC, Dinh T, Vevas A (2006) Microvascular changes in the diabetic foot. Int J Low Extreme Wounds 5:149–159
Jaap AJ, Shore AC, Stockman AJ et al (1996) Skin capillary density in subjects with impaired glucose tolerance and patients with type 2 diabetes. Diabet Med 13:160–164
Lincoln NB, Radford KA, Game FL, Jeffcoate WJ (2008) Education for secondary prevention of foot ulcers in people with diabetes: a randomised controlled trial. Diabetologia 51:1954–1961
Dargis V, Pantelejeva O, Jonushaite A, Vileikyte L, Boulton AJ (1999) Benefits of a multidisciplinary approach in the management of recurrent diabetic foot ulceration in Lithuania: a prospective study. Diabetes Care 22:1428–1431
American Diabetes Association (2019) 11. Microvascular complications and foot care: standards of medical care in diabetes—2019. Diabetes Care 42(Suppl 1):S124–S138
American Diabetes Association (2003) Peripheral arterial disease in people with diabetes. Diabetes Care 26:3333–3341
Hingorani A, LaMuraglia GM, Henke P et al (2016) The management of diabetic foot: a clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine. J Vasc Surg 63(Suppl):3S–21S
Bus SA, van Netten JJ (2016) A shift in priority in diabetic foot care and research: 75% of foot ulcers are preventable. Diabetes Metab Res Rev 32(Suppl 1):195–200
Armstrong DG, Bharara M, White M et al (2012) The impact and outcomes of establishing an integrated interdisciplinary surgical team to care for the diabetic foot. Diabetes Metab Res Rev 28:514–518
Chakraborti C, Le C, Yanofsky A (2010) Sensitivity of superficial cultures in lower extremity wounds. J Hosp Med 5:415–420
Pellizzer G, Strazzabosco M, Presi S, Furlan F, Lora L, Benedetti P, Bonato M, Erle G, de Lalla F (2001) Deep tissue biopsy vs. superficial swab culture monitoring in the microbiological assessment of limb-threatening diabetic foot infection. Diabet Med 18:822–827
Nelson EA, Wright-Hughes A, Brown S, Lipsky BA, Backhouse M, Bhogal M, Ndosi M, Reynolds C, Sykes G, Dowson C, Edmonds M, Vowden P, Jude EB, Dickie T, Nixon J (2016) Concordance in diabetic foot ulceration: a cross-sectional study of agreement between wound swabbing and tissue sampling in infected ulcers. Health Technol Assess 20:1–176
Rhee SM, Han SK, Kim WK (2010) Difference of microbiology according to tissue sampling in diabetic ulcers. J Korean Soc Plast Reconstr Surg 37:1–6
Lipsky BA, Aragon-Sanchez J, Diggle M, Embil J, Kono S, Lavery L, Senneville E, Urbančič-Rovan V, Van Asten S, Peters EJ, International Working Group on the Diabetic Foot (2016) IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes. Diabetes Metab Res Rev 32(Suppl 1):45–74
Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJ, Armstrong DG, Deery HG, Embil JM, Joseph WS, Karchmer AW, Pinzur MS, Senneville E, Infectious Diseases Society of America (2012) 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 54:e132–e173
Lipsky BA, Berendt AR, Deery HG et al (2004) IDSA guidelines: diagnosis and treatment of diabetic foot infections. Clin Infect Dis 39:885–910
Lipsky BA (2004) A report from the international consensus on diagnosing and treating the infected diabetic foot. Diabetes Metab Res Rev 20(Suppl 1):S68–S77
Wagner A, Reike H, Angelkort B (2001) Highly resistant pathogens in patients with diabetic foot syndrome with special reference to methicillin-resistant Staphylococcus aureus infections (in German). Dtsch Med Wochenschr 126:1353–1356
Tentolouris N, Petrikkos G, Vallianou N et al (2006) Prevalence of methicillin-resistant Staphylococcus aureus in infected and uninfected diabetic foot ulcers. Clin Microbiol Infect 12:186–189
Lipsky BA, Armstrong DG, Citron DM, Tice AD, Morgenstern DE, Abramson MA (2005) Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial. Lancet 366:1695–1703
Lipsky BA, Pecoraro RE, Wheat LJ (1990) The diabetic foot. Soft tissue and bone infection. Infect Dis Clin North Am 4:409–432
Lee JS, Son ST, Han SK (2017) Risk factors of methicillin-resistant Staphylococcus aureus and Pseudomonas infection in diabetic foot ulcers in Korea. J Wound Manag Res 13:29–34
Chung CH, Kim DJ, Kim J, Kim H, Kim H, Min KW, Park SW, Park JH, Baik SH, Son HS, Ahn CW, Oh JY, Lee S, Lee J, Choi KM, Choi I, Park IB (2006) Current status of diabetic foot in Korean patients using national health insurance database. J Korean Diabetes Assoc 30:372–376
Korean Society for Diabetic Foot (2014) Korean guideline for management of diabetic foot, 1st edn. Koonja Press, Seoul, pp 49–66
Bus SA, Armstrong DG, van Deursen RW, Lewis JE, Caravaggi CF, Cavanagh PR (2016) IWGDF guidance on footwear and offloading interventions to prevent and heal foot ulcers in patients with diabetes. Diabetes Metab Res Rev 32(Suppl 1):25–36
Bus SA, Waaijman R, Arts M, de Haart M, Busch-Westbroek T, van Baal J, Nollet F (2013) Effect of custom-made footwear on foot ulcer recurrence in diabetes: a multicenter randomized controlled trial. Diabetes Care 36:4109–4116
Frykberg RG, Gordon IL, Reyzelman AM, Cazzell SM, Fitzgerald RH, Rothenberg GM, Bloom JD, Petersen BJ, Linders DR, Nouvong A, Najafi B (2017) Feasibility and efficacy of a smart mat technology to predict development of diabetic plantar ulcers. Diabetes Care 40:973–980
Lavery LA, Higgins KR, Lanctot DR, Constantinides GP, Zamorano RG, Athanasiou KA, Armstrong DG, Agrawal CM (2007) Preventing diabetic foot ulcer recurrence in high-risk patients: use of temperature monitoring as a self-assessment tool. Diabetes Care 30:14–20
Najafi B, Mohseni H, Grewal GS, Talal TK, Menzies RA, Armstrong DG (2017) An optical-fiber-based smart textile (smart socks) to manage biomechanical risk factors associated with diabetic foot amputation. J Diabetes Sci Technol 11:668–677
Baron EJ (2011) Conventional versus molecular methods for pathogen detection and the role of clinical microbiology in infection control. J Clin Microbiol 49(Suppl 9):S43
Melendez JH, Frankel YM, An AT, Williams L, Price LB, Wang NY et al (2010) Real-time PCR assays compared to culture-based approaches for identification of aerobic bacteria in chronic wounds. Clin Microbiol Infect 16:1762–1769
Lavigne JP, Sotto A, Dunyach-Remy C, Lipsky BA (2014) New molecular techniques to study the skin microbiota of diabetic foot ulcers. Adv Wound Care 4:38–49
Babalola O (2003) Molecular techniques: an overview of methods for the detection of bacteria. Africa J Biotechnol 2:710–713
Dowd SE, Wolcott RD, Sun Y, McKeehan T, Smith E, Rhoads D (2008) Polymicrobial nature of chronic diabetic foot ulcer biofilm infections determined using bacterial tag encoded FLX amplicon pyrosequencing (bTEFAP). PLoS One 3:e3326
Noor S, Raghav A, Parwez I, Ozair M, Ahmad J (2018) Molecular and culture based assessment of bacterial pathogens in subjects with diabetic foot ulcer. Diabetes Metab Syndr 12(3):417–421
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Ashraf, H., Ahmad, J., Akhtar, A. (2021). Advances in Prevention and Empirical Treatment of Diabetic Foot Infection. In: Zubair, M., Ahmad, J., Malik, A., Talluri, M.R. (eds) Diabetic Foot Ulcer. Springer, Singapore. https://doi.org/10.1007/978-981-15-7639-3_12
Download citation
DOI: https://doi.org/10.1007/978-981-15-7639-3_12
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-7638-6
Online ISBN: 978-981-15-7639-3
eBook Packages: MedicineMedicine (R0)